Elo Mutual Pension Insurance Co Raises Holdings in Aflac Incorporated (NYSE:AFL)

Elo Mutual Pension Insurance Co increased its stake in shares of Aflac Incorporated (NYSE:AFL) by 12.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 53,816 shares of the financial services provider’s stock after acquiring an additional 6,167 shares during the quarter. Elo Mutual Pension Insurance Co’s holdings in Aflac were worth $5,567,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently bought and sold shares of AFL. Whipplewood Advisors LLC purchased a new position in shares of Aflac in the fourth quarter worth $26,000. BankPlus Trust Department purchased a new position in shares of Aflac in the fourth quarter valued at about $34,000. Curio Wealth LLC bought a new position in shares of Aflac during the fourth quarter valued at about $36,000. Raelipskie Partnership purchased a new stake in shares of Aflac during the third quarter worth about $38,000. Finally, OFI Invest Asset Management bought a new stake in shares of Aflac in the fourth quarter worth about $38,000. Institutional investors own 67.44% of the company’s stock.

Aflac Trading Up 0.4 %

NYSE AFL opened at $110.87 on Friday. The stock’s fifty day moving average price is $106.42 and its 200-day moving average price is $107.66. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. The stock has a market cap of $60.60 billion, a P/E ratio of 11.55, a P/E/G ratio of 3.24 and a beta of 0.93. Aflac Incorporated has a 12 month low of $79.31 and a 12 month high of $115.50.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, equities analysts forecast that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Insider Activity

In other news, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the sale, the director now directly owns 49,962 shares in the company, valued at $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Joseph L. Moskowitz sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the transaction, the director now directly owns 25,393 shares of the company’s stock, valued at $2,733,048.59. The trade was a 3.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Wells Fargo & Company lowered their price target on Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 19th. Evercore ISI dropped their price target on Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a research note on Wednesday, December 4th. JPMorgan Chase & Co. boosted their price objective on shares of Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a research report on Tuesday, January 7th. Keefe, Bruyette & Woods reduced their price target on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a research report on Wednesday, February 12th. Finally, StockNews.com raised Aflac from a “sell” rating to a “hold” rating in a research report on Friday, February 14th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $103.36.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.